SEC Form 4 · accession 0001140361-18-003152
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald R Taylor
Director
Period of report
Jan 24, 2018
Accepted (ET)
Jan 25, 2018 · 12:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Jan 24, 2018 | S | 4,885 | $99.71 | D | 21,751 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $99.43 to $99.90. The price reported above reflects the weighted average sale price.